Story
CarMax Stock Surges on Strong Earnings Beat and Sales Rebound

Summary
CarMax reported fiscal second-quarter results that far exceeded analyst expectations, driven by a 13% jump in same-store sales and plans to resume its share buyback program.
Shares of CarMax (KMX) rose more than 3% in pre-market trading after the used-vehicle retailer announced fiscal second-quarter 2027 results that significantly beat Wall Street forecasts, signaling a potential turnaround in its sales performance.
Quarterly Results Exceed Expectations
CarMax reported earnings per share (EPS) of $1.16, substantially higher than the consensus analyst estimate of approximately $0.73. The company's revenue also surpassed expectations, coming in at $7.88 billion against a forecast of around $7.03 billion. This represents a year-over-year revenue increase of nearly 19.5%.
Sales Growth and Strategic Shifts
A critical highlight for investors was the strong rebound in vehicle sales. According to the report, comparable store used unit sales climbed 13.0%, ending a streak of four consecutive quarters of year-over-year declines. Total used unit sales increased 13.8% to over 227,000 vehicles.
AdThe quarter also saw a strategic trade-off, with gross profit per retail used unit falling by $111 to $2,105. This move was attributed to pricing adjustments aimed at driving higher sales volume. Further boosting investor confidence, management announced plans to resume its share repurchase program in the third fiscal quarter, a move that had been previously paused.
Market Context
The stock's advance was largely company-specific, standing out against a muted broader market where the S&P 500 and Nasdaq showed only modest gains in early trading. The strong results provided a significant positive surprise to the market, where most analysts had maintained "hold" ratings on the stock amid concerns over valuation and execution risk.
Read next
More on Stocks
Netflix Stock Gains After Deutsche Bank Upgrades to 'Buy'
Shares of the streaming giant rose after Deutsche Bank upgraded the stock to 'Buy' from 'Hold,' setting a $95 price target and citing a valuation opportunity following a prolonged selloff.

Amazon, GoodRx Prescription Subscriptions Gain Traction Amid Rising US Healthcare Costs
Amazon and GoodRx are seeing significant growth in their prescription drug subscription services as consumers seek alternatives to rising insurance premiums and out-of-pocket expenses.

SEC Proposes Scaling Back Sarbanes-Oxley Auditor Requirements
The U.S. Securities and Exchange Commission plans to reduce the number of companies required to have external auditors verify internal financial controls, a key post-Enron investor protection.

Target Cuts Prices on Nearly 2,000 Items Ahead of Holiday Shopping Season
The retailer is reducing prices on home goods, apparel, and accessories to attract budget-conscious consumers amid a competitive retail environment and cautious spending.